OCUL

Ocular Therapeutix, Inc.

9.87 USD
+0.00 (+0.05%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Ocular Therapeutix, Inc. stock is up 111.7% since 30 days ago. The next earnings date is Mar 8, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 80% of the previous 9 February’s closed higher than January. In the last 10 Unusual Options Trades, there were 7 CALLs, 3 PUTs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
11 Jan 16:47 17 Jan, 2025 5.00 CALL 250 441
12 Jan 20:29 19 Jan, 2024 2.00 CALL 250 352
15 Feb 15:20 17 Jan, 2025 5.00 CALL 861 978
16 Feb 17:35 21 Jun, 2024 6.00 PUT 748 0
22 Feb 15:04 19 Apr, 2024 10.00 CALL 200 36
22 Feb 15:12 19 Apr, 2024 10.00 CALL 200 36
22 Feb 15:47 15 Mar, 2024 6.00 CALL 3000 3914
22 Feb 17:02 15 Mar, 2024 4.50 CALL 50 518
23 Feb 19:20 15 Mar, 2024 9.00 PUT 961 131
23 Feb 20:55 19 Apr, 2024 10.00 PUT 220 60

About Ocular Therapeutix, Inc.

Ocular Therapeutix, Inc. focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cataract surgery. It is also developing OTX-TKI, an axitinib intravitreal implant that is in phase 1 clinical trials for the treatment of wet age-related macular degeneration and other retinal diseases.

  • HC Wainwright & Co.
    Wed Feb 14, 06:23
    buy
    confirm
  • Bank of America
    Fri Feb 9, 07:23
    buy
    initial